Longevytum – Longevity Clinic in Madrid, Spain

Clinic Overview

Longevytum operates as a medical unit specialising in predictive, preventive, and personalised longevity care, integrated within the Instituto Montemauro in Madrid. Led by Dr. Jesús Esquide, the clinic is designed to integrate efficiently into the schedules of executives, founders, and high-performers who value discretion, precision, and time efficiency.

The clinic's clinical framework centres on Potentially Preventable Premature Mortality (PPPM) a structured approach to identifying the biological drivers of avoidable early death during their silent, pre-symptomatic phase. Advanced diagnostic tools including Coronary Calcium Score and Coronary Angiotax (CT) are used to identify cardiovascular risk patterns before symptoms appear. Longevytum is often discussed among leading longevity clinics in Europe, particularly those focusing on predictive diagnostics and preventive medicine.Within the growing ecosystem of preventive longevity clinics in Spain, Longevytum is known for its diagnostics-first approach to risk identification

At a Glance – Longevytum

Many patients choose to arrive in Madrid a day early or extend their stay briefly after completing appointments at Longevytum. This allows for a controlled transition before returning to full professional demands, without requiring a dedicated recovery stay.

The map below highlights nearby premium hotels and serviced apartments commonly used for pre- or post-appointment stays.

Use the Quick Links below to navigate directly to the sections most relevant to your visit.

🔗 Quick Links

• Clinic Overview
• Purpose & Executive Profile
• Medical Philosophy – Medicine 3.0
• Advanced Diagnostics & Medical Assessment
• What the Clinic Does Best
• Executive Outcomes
• Signature Longevity & Medical Programs
• Therapies, Facilities & Clinical Environment
• Pricing, Program Structure & Length of Stay
• Plan Your Stay at Longevytum
• Outcomes & Reputation
• How to Think About Longevytum
• Frequently Asked Questions

Purpose & Executive Profile

Clinical Purpose

The clinical purpose of Longevytum is to identify risk before disease, using advanced diagnostics to detect biological deterioration during its subclinical or silent phase.

Rather than focusing on treatment, the clinic supports:

• Early risk identification
• System-level understanding of aging
• Long-term planning based on measurable data

Who This Clinic Is Designed For

Many professionals evaluating preventive executive health programs seek clinics that prioritize early risk detection rather than lifestyle retreats.Longevytum is designed for individuals who are:

• Executives and senior decision-makers
• Founders and entrepreneurs
• Investors managing long planning horizons
• Athletes and performance-driven professionals

The clinic is not intended for:

• Acute medical care
• Symptom-driven consultations
• Wellness, spa, or retreat-style programs

Focus Areas Overview

Medical Philosophy – Medicine 3.0

Longevytum, under the direction of Dr. Jesús Esquide, operates within a Medicine 3.0 framework that shifts healthcare from reacting to disease toward anticipating and managing risk over time.

A defining feature of the clinic's philosophy is its specific focus on Potentially Preventable Premature Mortality (PPPM) a clinically structured concept that identifies the leading causes of avoidable early death and intervenes during the biological phase when prevention is still possible. The five primary PPPM domains addressed by the clinic are:

• Cardiovascular disease: the leading global cause of premature death, frequently developing silently over decades

• Cancer: particularly hereditary and early-onset oncological risk

• Metabolic dysfunction: including insulin resistance, diabetes, and visceral fat accumulation

• Physical and cognitive decline: functional capacity as a measurable mortality predictor

• Biological ageing acceleration: telomere and molecular markers of accelerated cellular wear

By targeting PPPM specifically, Longevytum goes beyond general longevity assessment to focus clinical energy where the evidence for preventive impact is strongest.

 

Core System Focus

Longevytum concentrates on biological systems most strongly associated with PPPM and avoidable premature mortality:

• Cardiovascular integrity

• Metabolic regulation

• Chronic inflammation

• Physical and cognitive function

Lifestyle as a Medical Tool

Lifestyle factors sleep duration, movement capacity, nutrition quality, and stress exposure are assessed as measurable biological inputs, not wellness choices. Some emerging studies also examine adaptogens and medicinal mushrooms in longevity research, particularly for their potential influence on cellular stress resilience

Advanced Diagnostics & Medical Assessment

The clinic’s diagnostic model resembles a comprehensive executive health check for longevity, combining biomarkers, imaging, and physician interpretation.

Longevytum, under Dr. Jesús Esquide, applies a diagnostics-first framework designed to identify biological risk during the silent phase of disease when deterioration is measurable but symptoms are often absent.

The clinic combines molecular, genetic, functional, and imaging data to create a system-level risk profile. All findings are reviewed by Dr. Esquide and presented as probabilistic risk indicators within the PPPM framework.

 

Diagnostic Assessment Includes

Why Coronary Calcium Score and Coronary Angiotax Matter

These two named imaging tools are central to Longevytum's cardiovascular PPPM methodology:

Coronary Calcium Score quantifies the degree of calcified plaque in coronary arteries — one of the strongest independent predictors of future cardiovascular events. It identifies silent atherosclerosis years before symptoms appear.

Coronary Angiotax (CT) is a coronary CT angiography that directly visualises coronary artery anatomy, detecting blockages and structural changes that blood tests cannot identify. Together, these tools allow Dr. Esquide to stratify cardiovascular risk with precision not achievable through standard clinical panels.

Chronomedicine & Future Risk Mapping

Longevytum applies a chronomedicine perspective, assessing how biological systems change over time rather than viewing health as a static snapshot. This approach allows clinicians to identify when risk acceleration may occur and where preventive planning may still be effective.

This model is especially relevant for individuals aged 35 and above, a period identified in longevity research as the point where biological decline begins to accelerate measurably.

What the Clinic Does Best

Longevytum's strength, under Dr. Jesús Esquide, is not in offering treatments but in structuring biological uncertainty around the PPPM framework.
The clinic specializes in identifying biological risk early, interpreting complex diagnostic signals, and maintaining longitudinal oversight as biology changes over time. Studies show that cardiorespiratory fitness declines by approximately 8–10% per decade after midlife (American College of Cardiology and longitudinal cohort studies), which is why longitudinal monitoring is emphasized over single-point evaluation.

Key Medical Strength 1: Silent Cardiovascular & Oncological Risk Detection

Longevytum's clinical focus on Potentially Preventable Premature Mortality (PPPM) means that diagnostic resources are directed specifically at the risk domains with the highest potential for preventive impact cardiovascular disease, cancer, metabolic dysfunction, functional decline, and biological ageing acceleration.

The clinic applies Coronary Calcium Score and Coronary Angiotax (CT) to detect arterial blockages, inflammatory burden, and early cardiovascular indicators before they trigger events.

 

Key Medical Strength 2: Biological Age Measurement Over Chronological Age

Telomere analysis and molecular biomarkers assess how quickly cellular systems are degrading relative to population norms interpreted by Dr. Jesús Esquide within the PPPM risk framework. 

Key Medical Strength 3: Functional Capacity as a Core Longevity Signal

Physical autonomy is treated as a measurable medical variable within the PPPM model. Strength, mobility, and ergometric testing confirm whether biological risk is translating into functional decline one of the most predictive mortality indicators.

Key Medical Strength 4: Longitudinal Monitoring Through the Active Aging Plan

Periodic testing tracks changes in biological markers over time, allowing Dr. Esquide to detect PPPM risk acceleration early and adjust the monitoring strategy accordingly.

Key Medical Strength 5: Precision Imaging for Subclinical Disease

Coronary Calcium Score and Coronary Angiography (CT) identify structural cardiovascular changes that traditional blood tests cannot detect, enabling risk identification at a stage where intervention decisions remain open.

Executive Outcomes

Longevytum documents outcomes in terms of risk awareness, decision clarity, and planning confidence, not cures or performance guarantees. The following summaries reflect patterns reported in clinic-published materials and patient testimonials.

Outcome 1 – From Uncertainty to Structured Risk Awareness

Before:
Limited visibility into silent cardiovascular, metabolic, or inflammatory risk. Standard checkups indicated values “within range,” offering reassurance but little long-term insight.

After:
Clear identification of biological risk patterns using molecular markers, functional testing, and precision imaging—allowing informed discussions with personal physicians.

Source:
Longevytum patient-reported experiences and clinical summaries.

Signature Longevity & Medical Programs

Longevytum offers tiered diagnostic programs aligned with different levels of risk assessment and monitoring depth.

Programs are designed for evaluation and monitoring, not treatment.

Program Overview

Therapies, Facilities & Clinical Environment

Longevytum is structured as a medical unit, not a treatment center or wellness space. Its environment, facilities, and supportive therapies exist to enable accurate diagnostics, preserve functional capacity, and support long-term monitoring, rather than to deliver restorative experiences.

All services operate within a physician-led, diagnostics-first framework.

Medical & Supportive Therapies

Therapies at Longevytum are positioned as supportive clinical services to maintain function, mobility, and physiological stability as part of a broader longevity strategy.

These may include:

• Physician-supervised preventive protocols
• Physiotherapy focused on mobility and musculoskeletal resilience
• Functional rehabilitation assessments
• Pelvic floor and posture-focused evaluations where relevant

Therapies are not presented as treatments or cures, but as adjuncts to risk management and functional preservation.

Clinical Facilities

Longevytum’s facilities support deep diagnostic precision, enabling physicians to identify risk patterns that are not detectable through standard checkups.

Key clinical infrastructure includes:

• Advanced molecular and biochemical analysis labs
• Precision imaging access (including coronary CT angiography and calcium scoring)
• Genetic and hereditary risk assessment tools
• Functional and ergometric testing areas
• Body composition and bone density (DEXA) scanning

Architecture, Environment & Digital Discipline

The clinic environment is intentionally clinical, discreet, and efficiency-oriented. Design choices prioritize accuracy, privacy, and time discipline rather than sensory stimulation.

Key characteristics include:

• Quiet consultation spaces for physician interpretation
• Minimal waiting time and structured scheduling
• Strong data protection and GDPR-compliant workflows
• Controlled digital environments to reduce distraction

Pricing, Program Structure & Length of Stay

Longevytum presents pricing as a function of PPPM diagnostic depth and longitudinal oversight under Dr. Jesús Esquide, not therapeutic intensity or amenities.

Pricing 

Pricing Notes

How Programs Are Structured

Longevytum programs follow a standardized medical workflow designed to maximize diagnostic clarity while minimizing time burden for high-performers.

Typical flow includes:

1. Pre-visit preparation
   Review of health history, previous data, and planning objectives.
2. On-site diagnostics
   Biomarkers, functional testing, and imaging as applicable.
3. Physician interpretation
   Integration of findings into a system-level risk overview.
4. Reporting
   Structured documentation positioned for review with a personal physician.

Length of Stay

Clinic: Longevytum

Medical Director: Dr. Jesús Esquide, Specialist in Aging and Longevity Medicine

Address: C/ Félix Boix 14, 28036 Madrid, Spain

Facility: Integrated within Instituto Montemauro

Longevytum is designed to integrate into existing professional schedules rather than requiring extended time away from work. Most visitors plan their stay around diagnostic appointments, with flexibility to arrive shortly before or depart shortly after assessments.

Plan Your Stay at Longevytum

Longevytum is designed to integrate into existing professional schedules rather than requiring extended time away from work. Most visitors plan their stay around diagnostic appointments, with flexibility to arrive shortly before or depart shortly after assessments.

The clinic does not operate as a residential facility. Stay planning is handled independently and is typically aligned with business travel or short personal visits.

Accommodation & Stay Planning

Longevytum does not provide on-site accommodation. Patients typically stay in nearby premium hotels or serviced apartments, selecting locations that support privacy, walkability, and efficient travel to the clinic.

🔗 Explore nearby hotels & apartments

How to Reach the Clinic

• Nearest Airport: Madrid–Barajas Adolfo Suárez Airport
• Access: Taxi, private transfer, or ride-hailing services
• Urban Connectivity: Well-connected via Madrid’s road and public transport network

🔗 Find best flights to Madrid
🔗 Find car rentals in Madrid

What to Bring

• Relevant prior medical reports or imaging (if available)
• Comfortable clothing suitable for functional assessments
• Any required identification or documentation requested in advance

No specialized equipment or extended preparation is typically required

Outcomes & Reputation

Longevytum’s reputation is built around diagnostic clarity, physician interpretation, and long-term oversight rather than short-term results. Reported outcomes focus on understanding risk, improving planning confidence, and establishing a structured health framework that can be revisited over time.

What Patients Commonly Report

Across clinic-published materials and verified testimonials, recurring themes include:

• Clear explanation of complex diagnostic findings
• Greater visibility into silent or subclinical risk patterns
• Confidence in discussing results with a personal physician
• Appreciation for a calm, non-urgent clinical tone
• Perception of the process as a long-term investment rather than a one-time intervention

Media & Professional Recognition

Longevytum’s clinical approach and public communication have been recognized across medical, business, and mainstream media channels. Coverage typically highlights the clinic’s focus on preventive longevity, biological age assessment, and the shift toward predictive medicine.

Professional credibility is reinforced through:

• Leadership by a physician with over 30 years of experience in national health system protocols
• Membership in European, Spanish, and Ibero-American scientific societies focused on longevity and age management
• Quality certification aligned with Madrid regional health standards
• A documented history of 2,500+ patient engagements

Media references and institutional affiliations are presented to support transparency and editorial trust, not endorsement.

How to Think About Longevytum

Longevytum is best understood as a diagnostics-first medical reference point, not a treatment provider or wellness destination.

The clinic’s purpose is to clarify long-term biological risk while options remain open. By combining advanced diagnostics with physician interpretation, it helps individuals understand how aging is progressing at a system level—often before conventional care surfaces any concern.

For executives and high-performers, the value lies in clarity without urgency. Longevytum supports informed, forward-looking health decisions without positioning itself as the decision-maker or solution.

Frequently Asked Questions

Is Longevytum a medical clinic or a wellness center?

Longevytum operates as a physician-led medical clinic focused on diagnostics, risk assessment, and long-term health planning. It does not function as a wellness center, spa, or retreat, and it does not offer experiential or lifestyle-based programs.

How personalised is the assessment?

Assessments are personalised through diagnostic interpretation, not through bespoke treatment plans. Diagnostic scope, imaging depth, and monitoring cadence are adapted to individual risk profiles and objectives, while medical decisions remain the responsibility of the patient and their personal physician.

Does the clinic provide medical treatment or prescriptions?

Longevytum focuses on assessment, interpretation, and monitoring. It does not position itself as a treatment provider, and it does not replace a patient’s primary healthcare team. Any medical decisions or interventions must be discussed with a personal physician.

How is privacy and data protection handled?

All medical data is handled under GDPR-compliant medical governance. Information is processed solely for clinical purposes, with patient consent, and is not shared with third parties except where legally required.

Can I stay connected and work during my visit?

Yes. The clinic is structured for professionals who remain operational during visits. Appointments are scheduled efficiently, and there are no digital restrictions imposed outside of consultation settings.

Is this clinic suitable for people with diabetes or chronic conditions?

Longevytum does not provide treatment for chronic conditions. However, individuals with existing diagnoses may use diagnostic assessments to better understand risk patterns and progression, in coordination with their treating physician.

How should value be evaluated relative to cost?

Value is best assessed in terms of:

• Diagnostic depth
• Physician interpretation time
• Long-term relevance of findings
• Clarity gained for future decision-making

The clinic’s services are positioned as strategic health intelligence, not short-term care.

A Strategic Pause That Protects the Years Ahead

Longevity planning is no longer a speculative interest or a lifestyle trend. For executives, founders, and high-performers, it has become a matter of risk management over time—the disciplined evaluation of factors that may influence cognitive capacity, physical autonomy, and decision-making decades into the future.

Longevytum exists for individuals who recognise that the most consequential health risks rarely announce themselves early. Cardiovascular disease, metabolic dysfunction, and systemic decline often develop quietly, long before they interfere with daily performance. By the time symptoms appear, options are narrower and decisions more constrained.

The clinic’s role is not to intervene, promise improvement, or replace primary care. Its purpose is to make uncertainty legible—to translate complex biological data into structured insight that can inform long-term planning. This includes understanding how biological age compares to chronological age, where functional capacity may be trending, and which risk factors merit closer attention over time.

For high-performers accustomed to managing financial, operational, and strategic exposure, this approach mirrors familiar decision frameworks. Information is gathered early. Interpretation is handled by specialists. Action remains deliberate, proportional, and personal.

Choosing to engage with a diagnostics-first longevity clinic is not an urgent decision. It is a measured one—a pause taken early enough to preserve optionality later. For those thinking in decades rather than quarters, that pause can shape how the years ahead are navigated.
You can explore additional top longevity clinics and preventive medicine centers across Europe in our clinic directory

 ↩ Return to ExtendMy.Life
  ⬆ Back to Top

Disclaimer

This page is provided for informational and editorial purposes only. It does not constitute medical advice, diagnosis, or treatment, and should not be relied upon as a substitute for consultation with a qualified healthcare professional. No doctor–patient relationship is established through the use of this content. All diagnostic assessments described indicate risk probability, not certainty, and individual outcomes may vary based on genetics, lifestyle, medical history, and external factors. Longevytum does not provide guarantees regarding health outcomes, disease prevention, or performance improvement. Any medical decisions, treatments, or interventions must be made in consultation with a personal physician or licensed medical provider who is familiar with the individual’s full medical history. All information is presented in accordance with applicable medical governance and data protection standards. References to diagnostics, programs, or methodologies are descriptive only and do not imply suitability for any specific individual.

References

Alzheimer’s Association (2023) Physical activity, exercise and Alzheimer’s disease.

British Medical Journal (BMJ) (2016) ‘Sleep duration and mortality: a systematic review and meta-analysis’, BMJ, 355, i5210.

European Medicines Agency (EMA) (2022) Guidance on clinical investigations and diagnostics.

European Society of Cardiology (ESC) (2021) ‘Guidelines on cardiovascular disease prevention in clinical practice’, European Heart Journal, 42(34), pp. 3227–3337.

Instituto Nacional de Estadística (INE) (2023) Population structure and centenarian statistics in Spain.

Journal of Cachexia, Sarcopenia and Muscle (2018) ‘Muscle strength and mortality risk in older adults’, Journal of Cachexia, Sarcopenia and Muscle, 9(1), pp. 3–18.

Journal of the American College of Cardiology (JACC) (2018) ‘Coronary artery calcium scoring and cardiovascular risk prediction’, Journal of the American College of Cardiology, 72(4), pp. 434–447.

National Institute on Aging (2022) Biology of aging and longevity research.

Nature Medicine (2018) ‘An epigenetic biomarker of aging for lifespan and healthspan’, Nature Medicine, 24(4), pp. 529–538.

New England Journal of Medicine (NEJM) (2015) ‘Preventive medicine and the aging population’, New England Journal of Medicine, 373(22), pp. 2093–2096.

The Lancet (2019) ‘Global burden of cardiovascular disease’, The Lancet, 393(10191), pp. 1983–1992.

World Health Organization (WHO) (2023) Cardiovascular diseases (CVDs): Fact sheet.